PTIX: Total Utang marang Modal Protagenic

Logo perusahaan publik Protagenic Therapeutics (PTIX)

The success of Protagenic Therapeutics (PTIX) relies on the confirmed efficacy of TCAP peptides in combating anxiety. The share price history on GURU.Markets, where the indicator stands at 0.00, visualizes this process. The development of new hormones is being conducted in collaboration with neurocenters. However, the business has a critical dependence on a single drug, which creates a binary risk for the company's entire model.

PTIX - Total Utang marang Modal Protagenic ing rentang 04.07.2022 - 10.01.2026

Rincian metrik lan analitis perusahaan Protagenic Therapeutics, Inc. (PTIX)

- rega lan prakiraan konsensus rega:
Bagan rega Protagenic Therapeutics Inc.|PTIX - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar Protagenic Therapeutics|PTIX - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Akuntansi saben Saham Protagenic Therapeutics|PTIX - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku protagenic.com|PTIX - Nilai Agregat Aset
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Protagenic Therapeutics|PTIX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Protagenic Therapeutics Inc.|PTIX - Gunggung tanggungan utang perusahaan|Rasio utang marang kapitalisasi buku Protagenic Therapeutics|PTIX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Protagenic Therapeutics
Ringkesan analitik perusahaan:PTIX, Protagenic Therapeutics
Barang utama Protagenic Therapeutics Inc.

This ratio measures the degree of financial leverage by comparing total credit obligations to net assets to assess the stability of the capital structure. Analyzing the total debt-to-equity ratio allows for the determination of bankruptcy risks, which is critically important for Protagenic Therapeutics (PTIX) when financing ethical clinical trials and implementing strict ESG biosafety standards in the development of synthetic peptides.

Analisis pesaing Protagenic Therapeutics

Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|Utang marang Ekuitas Harmony Biosciences|biohavenpharma.com - Utang Agregat marang Ekuitas|Utang marang Ekuitas Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Praxis Medicines PRAX|Anavex Life Sciences Corp (AVXL) - Utang marang Modal|CBLL: Rasio Total Utang marang Ekuitas|Prothena Corporation PLC - Utang Agregat marang Modal|ALEC: Total Utang marang Modal|Annexon Biosciences (ANNX) - Total Utang marang Modal|OMER (Omeros Corp) - Total Utang marang Modal|NGNE - Rasio Utang marang Modal|Total Utang marang Modal ACIU|VYGR - Utang marang Modal|Utang marang Ekuitas Neumora Therapeutics, Inc. NMRA|SCLX: Rasio Utang marang Ekuitas|Tevogen Bio Holdings, Inc. - Total Utang marang Modal|Koefisien Total Utang marang Modal Alpha Cognition ACOG|CGTX: Total Utang marang Modal|Rasio Total Utang marang Ekuitas inhibikase.com|Rasio Total Utang marang Ekuitas SAVA|ASRT: Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas COYA (Coya Therapeutics, Inc.)|Utang Agregat marang Modal VTGN|Total Utang marang Modal OVID (Ovid Therapeutics)|Rasio Kabeh Utang marang Dana Pribadi ABOS|CervoMed - Total Utang marang Modal|Utang marang Modal Alterity Therapeutics|clene.com (CLNN) - Utang marang Ekuitas|PepGen - Rasio Kabeh Utang marang Dana Pribadi|JUNS (Jupiter Neurosciences Inc) - Total Utang marang Modal|Total Utang marang Modal relmada.com|Utang marang Ekuitas Annovis Bio (ANVS)|GRCE: Utang Agregat marang Ekuitas|Total Utang marang Modal AIFF (Firefly Neuroscience Inc)|ANEW Medical (KLTO) - Utang marang Modal|NRSN: Rasio Total Utang marang Ekuitas|RVPH - Total Utang marang Modal|MTVA (metaviatx.com) - Rasio Total Utang marang Ekuitas|NRXS: Utang Agregat marang Modal|HSDT (Helius Medical Technologies, Inc.) - Total Utang marang Modal|Passage Bio Corp (PASG) - Koefisien Total Utang marang Modal|Total Utang marang Modal NEUP|Rasio Total Utang marang Ekuitas minervaneurosciences.com NERV|Utang marang Ekuitas Athira Pharma ATHA|Koefisien Total Utang marang Modal Addex Therapeutics Ltd. (ADXN)|ALZN - Utang marang Ekuitas|Utang Agregat marang Ekuitas CYCN|KTTA (pasitheaclinics.com) - Rasio Total Utang marang Ekuitas|CRGT: Utang Agregat marang Modal|ATXI (Avenue Therapeutics, Inc.) - Total Utang marang Modal|Brainstorm Cell Therapeutics Inc. (BCLI) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas CARA (Cara Therapeutics, Inc)|Chromocell - Rasio Utang marang Ekuitas|Utang marang Ekuitas Eliem Therapeutics Inc. ELYM|ITCI: Rasio Utang marang Ekuitas|Longboard Pharmaceuticals, Inc. - Total Utang marang Modal|Utang marang Modal Marinus Pharmaceuticals Inc|NKGN (NKGen) - Rasio Total Utang marang Ekuitas|NeuroBo Pharma (NRBO) - Total Utang marang Modal|Utang marang Ekuitas Sage Therapeutics, Inc.|SNPX: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Trevena (TRVN)|VIGL - Utang marang Modal|Utang marang Ekuitas Anew Medical WENA|CERE (Cerevel Corp) - Utang Agregat marang Ekuitas